ArticleJournal of the American Chemical Society2026
Modular Framework for 3D Molecular Generation in Computational Chemistry Applications.
Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Three-dimensional molecular generative models construct molecules by assigning atoms explicit Cartesian coordinates. This formulation allows the molecular generation process to be guided by geometric (e.g., steric effects, molecular shape) and physicochemical constraints toward desired objectives in a given chemical problem. The practical adoption of these models, however, remains limited by two key challenges: the high computational cost associated with model training as well as the lack of standardized platforms that allow models to be developed, evaluated, and compared. The landscape of 3D generative models for molecular design is fragmented, with most methods developed for specific molecular generation objectives. The implementations of these models are scattered across different repositories, software environments, and evaluation protocols, which impedes reproducibility and controlled comparison of different approaches and, generally, limits broader adoption. Here, we introduce MolCraftDiffusion, a modular and extensible platform for building, deploying, and evaluating 3D molecular diffusion models in computational chemistry. Its layered architecture decouples core training logic from model definitions and task implementations, enabling new generative architectures, guidance strategies, and evaluation metrics to be integrated. As part of the package, we implement curriculum learning, a progressive chemical complexity training approach used to construct a pretrained diffusion model on 3D molecular data sets compiled from multiple sources, circumventing the cost of full training in downstream applications. The framework provides a modular set of guidance mechanisms for directing generation toward chemically relevant objectives: structure control via molecular inpainting (systematic exploration of structural variants around a reference) and outpainting (extending molecules with new chemical groups), and property-conditioned generation via gradient-based and classifier-free approaches. We illustrate these capabilities across computational chemistry tasks, including virtual library construction and inverse molecular design. The extensibility of the platform is further demonstrated by porting three architecturally distinct models from the literature: TABASCO, ADiT, and ShEPhERD, each integrated without modifications to the core codebase. The codebase, pretrained models, and examples are available at: https://github.com/lcmd-epfl/MolCraftDiffusion and https://huggingface.co/pregH/MolecularDiffusion.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.